Unique Pharma Trenbolone Acetate 100 Lab Test Results

Anabolic Lab
August 12, 2022

Summary

The product Trenbolone Acetate 100 mg/ml, manufactured by Unique Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number GH65721K, was submitted by the reseller Optitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Trenbolone Acetate, with a concentration of 93.52 mg/ml, falling 6.48% below the labeled claim of 100 mg/ml.

The testing process was conducted on 12 August 2022, with the sample retested twice to ensure accuracy. The results indicate underdosing, highlighting the importance of scrutinizing reseller-submitted samples to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.


Detailed Report

Product Overview

  • Manufacturer: Unique Pharma
  • Product Name: Trenbolone Acetate 100 mg/ml
  • Active Ingredient: Trenbolone Acetate
  • Batch Number: GH65721K
  • Expiration Date: Not provided
  • Delivery Method: Injectable

Sample Acquisition and Testing

  • Task Number: #22628
  • Client: Optitropin.EU
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: Optitropin.EU (Reseller)
  • Analysis Paid For By: Optitropin.EU

Testing Results

  • Specification: 100 mg/ml (as stated on the label)
  • Measured Concentration: 93.52 mg/ml
  • Accuracy: 93.52% (6.48% below the label claim)
  • Variance: -6.48%

Verification Details


Evaluation of Reseller-Submitted Testing

This analysis highlights a discrepancy in the tested product’s concentration, falling below the labeled claim. The submission and funding by the reseller Optitropin.EU warrant careful evaluation, as resellers may selectively test batches that meet high-quality standards. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings emphasize the need for independent validation through third-party testing across multiple batches to ensure product consistency.


Conclusion

The analysis reveals that Trenbolone Acetate 100 mg/ml is underdosed, with a measured concentration of 93.52 mg/ml. This result raises concerns about quality control for this batch and underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.


Disclaimer

This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.